Safety of direct oral anticoagulants in patients with advanced liver disease.

Georg Semmler Katharina Pomej David Josef Maria Bauer Lorenz Balcar Benedikt SimbrunnerTeresa BinterLukas HartlJeannette BeckerMatthias PinterPeter QuehenbergerMichael TraunerMattias Mandorfer J P Luyendyk Thomas Reiberger Bernhard Scheiner

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

Anticoagulants including DOACs should be used with caution in patients with advanced liver disease due to a significant rate of spontaneous bleeding events.

Keyphrases

direct oral anticoagulants
atrial fibrillation
venous thromboembolism